The Microdose GLP-1 Protocol ($129/month flat) offers another pathway for patients who experience mood sensitivity at standard doses, using lower starting concentrations to minimize neurological side effects while still achieving meaningful weight reduction
although this is uncommon, any history of hypersensitivity to niacinamide or NAD would be a contraindication
Common denial reasons include step therapy requirements, BMI criteria, or formulary exclusions
Which GLP-1 drug fits my medical history
8,129,343, which claims the semaglutide compound itself, the active ingredient in Novo Nordisk's Ozempic, Wegovy, and Rybelsus
However, N-acetylcysteine (NAC), a glutathione precursor, has the strongest clinical evidence and is used in NHS hospitals, making it a more reliable option despite not being a direct glutathione supplement